The global demand for Intragastric Balloon Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Intragastric balloon is basically a modern weight-loss procedure and one of the endoscopic treatment indicated for obesity. In this procedure, a saline-filled balloon is placed in individuals stomach, that helps in reducing weight by limiting how much an individual can eat. It also makes user feel full faster. This procedure for patients who cannot lose weight by any other means and are prone to serious health problems related to obesity.
Rising obesity epidemic worldwide, which effect more than 600 million people globally. According to WHO, approx. 65% of the world population live in countries where being overweight and obese kills more people than being under weight. These factor is propel the market growth. The other factors that propel the market growth are technological advancement in weight loss management and devices coupled with reduced cost associated with treatment. However, risks of acute pancreatitis and overinflation associated with intragastric balloon hampers the market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of intragastric balloon.
The entire intragastric balloon market has been sub-categorized into product, filling material and end-use. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Filling Material
- Single Intragastric Balloon
- Dual Intragastric Balloon
- Triple Intragastric Balloon
- Ambulatory Surgical Centers
This section covers regional segmentation which accentuates on current and future demand for intragastric balloon market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Intragastric Balloon Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intragastric balloon market include Allurion Technologies, Apollo Endosurgery, Inc., Districlass Medical SA, Endalis, Helioscopie Medical Implants, Lexel SRL, Halex Istar Indústria Farmacêutica Ltda (Medicone), Medsil, Obalon Therapeutics, Inc., Reshape Lifesciences Inc., Silimed Inc., Spatz FGIA Inc., and Shandong Institute of Medical Instruments. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.